We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Organizations conducting clinical trials will no longer have to submit routine GCP compliance reports that have been used to establish inspections with the UK’s Medicines and Healthcare products Regulatory Agency.